This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorantla, S.
Right arrow Articles by Poluektova, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorantla, S.
Right arrow Articles by Poluektova, L.

 Previous Article  |  Next Article 

Journal of Virology, March 2007, p. 2700-2712, Vol. 81, No. 6
0022-538X/07/$08.00+0     doi:10.1128/JVI.02010-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2–/–{gamma}c–/– Mice{triangledown}

Santhi Gorantla,1 Hannah Sneller,1 Lisa Walters,1 John G. Sharp,3 Samuel J. Pirruccello,4 John T. West,5 Charles Wood,5 Stephen Dewhurst,6 Howard E. Gendelman,1,2 and Larisa Poluektova1*

Center for Neurovirology and Neurodegenerative Disorders and Department of Pharmacology and Experimental Neuroscience and Departments of,1 Internal Medicine,2 Genetics, Cell Biology and Anatomy,3 Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska,4 Nebraska Center for Virology and School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska,5 Department of Microbiology and Immunology and James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York6

Received 14 September 2006/ Accepted 13 December 2006

The specificity of human immunodeficiency virus type 1 (HIV-1) for human cells precludes virus infection in most mammalian species and limits the utility of small animal models for studies of disease pathogenesis, therapy, and vaccine development. One way to overcome this limitation is by human cell xenotransplantation in immune-deficient mice. However, this has proved inadequate, as engraftment of human immune cells is limited (both functionally and quantitatively) following transplantation of mature human lymphocytes or fetal thymus/liver. To this end, a human immune system was generated from umbilical cord blood-derived CD34+ hematopoietic stem cells in BALB/c-Rag2–/–{gamma}c–/– mice. Intrapartum busulfan administration followed by irradiation of newborn pups resulted in uniform engraftment characterized by human T-cell development in thymus, B-cell maturation in bone marrow, lymph node development, immunoglobulin M (IgM)/IgG production, and humoral immune responses following ActHIB vaccination. Infection of reconstituted mice by CCR5-coreceptor utilizing HIV-1ADA and subtype C 1157 viral strains elicited productive viral replication and lymphadenopathy in a dose-dependent fashion. We conclude that humanized BALB/c-Rag2–/–{gamma}c–/– mice represent a unique and valuable resource for HIV-1 pathobiology studies.


* Corresponding author. Mailing address: 985880 Nebraska Medical Center, Omaha, NE 68198-5880. Phone: (402) 559-8926. Fax: (402) 559-3744. E-mail: lpoluekt{at}unmc.edu.

{triangledown} Published ahead of print on 20 December 2006.


Journal of Virology, March 2007, p. 2700-2712, Vol. 81, No. 6
0022-538X/07/$08.00+0     doi:10.1128/JVI.02010-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Brainard, D. M., Seung, E., Frahm, N., Cariappa, A., Bailey, C. C., Hart, W. K., Shin, H.-S., Brooks, S. F., Knight, H. L., Eichbaum, Q., Yang, Y.-G., Sykes, M., Walker, B. D., Freeman, G. J., Pillai, S., Westmoreland, S. V., Brander, C., Luster, A. D., Tager, A. M. (2009). Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice. J. Virol. 83: 7305-7321 [Abstract] [Full Text]  
  • Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., Gendelman, H. E. (2009). Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS. J. Immunol. 183: 661-669 [Abstract] [Full Text]  
  • Strowig, T., Gurer, C., Ploss, A., Liu, Y.-F., Arrey, F., Sashihara, J., Koo, G., Rice, C. M., Young, J. W., Chadburn, A., Cohen, J. I., Munz, C. (2009). Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. JEM 206: 1423-1434 [Abstract] [Full Text]  
  • Hofer, U., Baenziger, S., Heikenwalder, M., Schlaepfer, E., Gehre, N., Regenass, S., Brunner, T., Speck, R. F. (2008). RAG2-/-{gamma}c-/- Mice Transplanted with CD34+ Cells from Human Cord Blood Show Low Levels of Intestinal Engraftment and Are Resistant to Rectal Transmission of Human Immunodeficiency Virus. J. Virol. 82: 12145-12153 [Abstract] [Full Text]  
  • Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G., Steinman, R. M., Munz, C. (2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112: 1231-1239 [Abstract] [Full Text]  
  • Watanabe, S., Ohta, S., Yajima, M., Terashima, K., Ito, M., Mugishima, H., Fujiwara, S., Shimizu, K., Honda, M., Shimizu, N., Yamamoto, N. (2007). Humanized NOD/SCID/IL2R{gamma}null Mice Transplanted with Hematopoietic Stem Cells under Nonmyeloablative Conditions Show Prolonged Life Spans and Allow Detailed Analysis of Human Immunodeficiency Virus Type 1 Pathogenesis. J. Virol. 81: 13259-13264 [Abstract] [Full Text]  
  • Munk, C., Zielonka, J., Constabel, H., Kloke, B.-P., Rengstl, B., Battenberg, M., Bonci, F., Pistello, M., Lochelt, M., Cichutek, K. (2007). Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells. J. Virol. 81: 7048-7060 [Abstract] [Full Text]  
  • An, D. S., Poon, B., Fang, R. H. T., Weijer, K., Blom, B., Spits, H., Chen, I. S. Y., Uittenbogaart, C. H. (2007). Use of a Novel Chimeric Mouse Model with a Functionally Active Human Immune System To Study Human Immunodeficiency Virus Type 1 Infection. CVI 14: 391-396 [Abstract] [Full Text]